Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma

NCT02961816 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Lymphoma

Interventions

DRUG: Palifermin
DRUG: Panobinostat
DRUG: Gemcitabine
DRUG: Busulfan
DRUG: Melphalan
DRUG: Rituximab
DRUG: Dexamethasone
DRUG: Caphosol
DRUG: Glutamine
OTHER: Oral Cryotherapy (ice chips)
DRUG: Pyridoxine
BIOLOGICAL: Stem Cell Infusion
DRUG: G-CSF

Sponsor

M.D. Anderson Cancer Center